BACKGROUND & AIMS: The long-term clinical outcomes in initial survivors with acute liver failure (ALF) are not well known. The aim of this study was to provide an overview of the 2-year clinical outcomes among initial survivors and liver transplant (LT) recipients that were alive 3 weeks after enrolment in the Acute Liver Failure Study Group (ALFSG). METHODS: Outcomes in adult ALFSG patients that were enrolled between 1998 and 2010 were reviewed. RESULTS: Two-year patient survival was significantly higher in the 262 LT recipients (92.4%) compared to the 306 acetaminophen (APAP) spontaneous survivors (SS) (89.5%) and 200 non-APAP SS (75.5%) (P < 0.0001). The causes of death were similar in the three groups but the time to death was significantly longer in the LT recipients (P < 0.0001). Independent predictors of 2-year mortality in the APAP group were a high serum phosphate level and patient age (c-statistic = 0.65 (0.54, 0.76)), patient age and days from jaundice to ALF onset in the non-APAP group (c-statistic = 0.69 (0.60, 0.78)), and patient age, days from jaundice, and higher coma grade in the LT recipients (c-statistic = 0.74 (0.61, 0.87)). The LT recipients were significantly more likely to be employed and have a higher educational level (P < 0.05). CONCLUSIONS: Two-year outcomes in initial survivors of ALF are generally good but non-APAP patients have a significantly lower survival which may relate to pre-existing medical comorbidities. Spontaneous survivors with APAP overdose experience substantial morbidity during follow-up from ongoing psychiatric and substance abuse issues.
BACKGROUND & AIMS: The long-term clinical outcomes in initial survivors with acute liver failure (ALF) are not well known. The aim of this study was to provide an overview of the 2-year clinical outcomes among initial survivors and liver transplant (LT) recipients that were alive 3 weeks after enrolment in the Acute Liver Failure Study Group (ALFSG). METHODS: Outcomes in adult ALFSG patients that were enrolled between 1998 and 2010 were reviewed. RESULTS: Two-year patient survival was significantly higher in the 262 LT recipients (92.4%) compared to the 306 acetaminophen (APAP) spontaneous survivors (SS) (89.5%) and 200 non-APAPSS (75.5%) (P < 0.0001). The causes of death were similar in the three groups but the time to death was significantly longer in the LT recipients (P < 0.0001). Independent predictors of 2-year mortality in the APAP group were a high serum phosphate level and patient age (c-statistic = 0.65 (0.54, 0.76)), patient age and days from jaundice to ALF onset in the non-APAP group (c-statistic = 0.69 (0.60, 0.78)), and patient age, days from jaundice, and higher coma grade in the LT recipients (c-statistic = 0.74 (0.61, 0.87)). The LT recipients were significantly more likely to be employed and have a higher educational level (P < 0.05). CONCLUSIONS: Two-year outcomes in initial survivors of ALF are generally good but non-APAPpatients have a significantly lower survival which may relate to pre-existing medical comorbidities. Spontaneous survivors with APAPoverdose experience substantial morbidity during follow-up from ongoing psychiatric and substance abuse issues.
Authors: George Ostapowicz; Robert J Fontana; Frank V Schiødt; Anne Larson; Timothy J Davern; Steven H B Han; Timothy M McCashland; A Obaid Shakil; J Eileen Hay; Linda Hynan; Jeffrey S Crippin; Andres T Blei; Grace Samuel; Joan Reisch; William M Lee Journal: Ann Intern Med Date: 2002-12-17 Impact factor: 25.391
Authors: John J Potterat; Devon D Brewer; Stephen Q Muth; Richard B Rothenberg; Donald E Woodhouse; John B Muth; Heather K Stites; Stuart Brody Journal: Am J Epidemiol Date: 2004-04-15 Impact factor: 4.897
Authors: Javier Vaquero; Julie Polson; Chuhan Chung; Irene Helenowski; Frank V Schiodt; Joan Reisch; William M Lee; Andres T Blei Journal: Gastroenterology Date: 2003-09 Impact factor: 22.682
Authors: Elizabeth W Jackson; Steven Zacks; Sandra Zinn; John Ryan; Mark W Johnson; David A Gerber; Kenneth Andreoni; Jeffrey H Fair; Roshan Shrestha; Michael W Fried Journal: Liver Transpl Date: 2002-10 Impact factor: 5.799
Authors: K Rajender Reddy; Caitlyn Ellerbe; Michael Schilsky; R Todd Stravitz; Robert J Fontana; Valerie Durkalski; William M Lee Journal: Liver Transpl Date: 2016-04 Impact factor: 5.799
Authors: Robert J Fontana; Paul H Hayashi; Huiman Barnhart; David E Kleiner; K Rajender Reddy; Naga Chalasani; William M Lee; Andrew Stolz; Thomas Phillips; Jose Serrano; Paul B Watkins Journal: Am J Gastroenterol Date: 2015-09-08 Impact factor: 10.864
Authors: Constantine J Karvellas; Filipe S Cardoso; Michelle Gottfried; K Rajender Reddy; A James Hanje; Daniel Ganger; William M Lee Journal: Clin Gastroenterol Hepatol Date: 2016-06-13 Impact factor: 11.382
Authors: Filipe S Cardoso; Mark J Mcphail; Constantine J Karvellas; Valentin Fuhrmann; Nuno Germano; Georg Auzinger Journal: GE Port J Gastroenterol Date: 2021-05-25